Results 11 to 20 of about 8,073,410 (232)
Immunopathogenesis of ANCA-Associated Vasculitis [PDF]
International Journal of Molecular Sciences, 2020 Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is an autoimmune disorder which affects small- and, to a lesser degree, medium-sized vessels. ANCA-associated vasculitis encompasses three disease phenotypes: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA).
Andreas Kronbichler +32 more
core +14 more sources
Pathogenesis of ANCA-associated Vasculitis [PDF]
Rheumatic Disease Clinics of North America, 2010 Antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) comprises a group of systemic inflammatory vasculitides associated with circulating autoantibodies directed against the neutrophil granule components proteinase 3 and myeloperoxidase.
Julia, Flint +2 more
openaire +3 more sources
ANCA associated vasculitis subtypes: Response (response to letter) [PDF]
, 2022 Many thanks for the opportunity to respond to the interesting letter to the Editor from Merkel, Jayne, and Bekker, with regard to our publication “ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives”.1In the management section of
Robson, Joanna C +6 more
core +1 more source
Frontiers in Immunology, 2021 BackgroundAnti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a small vessel vasculitis in adults and children that commonly affects the kidneys.
Kristen M. Gibson +9 more
doaj +1 more source
Archives of Medical Science, 2020 Introduction Anti-neutrophilic cytoplasmic antibody (ANCA) has been reported in systemic sclerosis (SSc). Some clinical features of SSc can also be presented with ANCA-associated vasculitis.
Ajanee Mahakkanukrauh +3 more
doaj +1 more source
ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
European Journal of Medical Research, 2021 Background Systemic sclerosis (SSc) and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) both affect the kidney and may cause renal failure. Treatment of AAV is dramatically different from that of SSc renal crisis (SRC).
Rui Wu, Jiang Su, Yu-rong Zou, Jing Zhu
doaj +1 more source
ANCA-associated renal vasculitis [PDF]
Kidney International, 2002 To the Editor: The Nephrology Forum discussed by Professor Savage reminded us of two items about ANCA-associated renal vasculitis (AARV): (1) the complex pathogenesis, where ANCA are much but not enough; and (2) the role of cytokines1.
Campo A, Grill A, STRATTA, Piero
openaire +2 more sources
The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis
Antibodies, 2019 Considerable progress has been made in understanding the role of autoantibodies in systemic vasculitides (SV), and consequently testing for anti-neutrophil cytoplasmic antibodies (ANCA), anti-glomerular basement membrane antibodies (anti-GBM), and anti ...
Elena Csernok
doaj +1 more source
Checkpoint inhibitor-related renal vasculitis and use of rituximab
Journal for ImmunoTherapy of Cancer, 2020 The percentage of patients with cancer eligible for checkpoint inhibitor (CPI) therapy has increased rapidly over the past few years and approaches 45%.
Noha Abdel-Wahab +6 more
doaj +1 more source
ANCA Associated Vasculitis Treated with Ultra-low Dose Rituximab: A Case Report
Xiehe Yixue Zazhi, 2023 We reported a case of ANCA-associated vasculitis with pulmonary and renal involvement that was effectively treated with glucocorticoids, cyclophosphamide, and plasma exchange therapy.
WU Haiting, LI Hang
doaj +1 more source